Avalo Therapeutics Inc. buy Wedbush
Start price
21.02.25
/
50%
€0.041
Target price
21.02.26
€17.18
Performance (%)
-
End price
22.02.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Avalo Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -3.640% | -8.784% | -0.694% |
| iShares Nasdaq 100 | -2.986% | -1.710% | 11.948% |
| iShares Nikkei 225® | -3.000% | -9.097% | 23.387% |
| iShares S&P 500 | -2.389% | -2.781% | 7.620% |
Comments by Wedbush for this prediction
In the thread Avalo Therapeutics Inc. diskutieren
Avalo Therapeutics, Inc. (NASDAQ: AVTX) is now covered by analysts at Wedbush. They set an "outperform" rating and a $18.00 price target on the stock.
Ratings data for AVTX provided by MarketBeat
In the thread Trading Avalo Therapeutics Inc.
Die von Wedbush gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Wedbush for Avalo Therapeutics Inc.
Avalo Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.041
20.03.25
20.03.25
€16.51
20.03.26
20.03.26
-
21.03.26
21.03.26
